fbpx
close read more
News

Nicolas Lévy joins Servier as Chief Scientist Rare Diseases

06/05/2022

Nicolas Lévy joins Servier as Chief Scientist Rare Diseases

Nicolas Lévy, MD, PhD was appointed Chief Scientist Rare Diseases of the Servier Group.

His mission is to ensure the acceleration of Servier’s research and development pipeline of projects that are focused on small targeted populations of patients with rare and ultra-rare diseases. He will also actively contribute to strengthen the translational medicine approach initiated by the Group.

“I am delighted to welcome Nicolas Lévy to our global R&D Division. Nicolas Lévy’s scientific and medical expertise in rare disease is deeply recognized at national and international levels and I am convinced he will bring extraordinary knowledge and experience to support our ambitions in this field,” said Claude Bertrand, Executive Vice President of Research and Development at Servier.

Nicolas Lévy is a clinician and Professor of Human and Medical Genetics, who has been committed to patients affected with rare diseases for over 30 years.

“I am delighted to join Servier with the shared ambition to accelerate pipeline advancements from research to clinical stages and to get the opportunity to deliver new therapeutic solutions to patients. I am looking forward to being part of this journey with the teams and in such a dynamic, motivated and scientifically excellent environment,” said Nicolas Lévy.

Read the press release

Last news

News
23/06/2022
Meeting the challenge of adherence: a Servier study presented at the ESH 2022 Annual Meeting!
News
15/06/2022
Appointment of Angelo Paci, Oncology & Immuno-Oncology Program Leader
News
01/06/2022
Patient associations’ perception of pharmaceutical companies: Servier is making progress!